A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 28 513.3 INR Market Closed
Market Cap: 605.9B INR
Have any thoughts about
Abbott India Ltd?
Write Note

Abbott India Ltd
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott India Ltd
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
Abbott India Ltd
NSE:ABBOTINDIA
Change in Working Capital
-â‚ą2.8B
CAGR 3-Years
-7%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Change in Working Capital
-â‚ą55.9B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Change in Working Capital
-â‚ą23.7B
CAGR 3-Years
-36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Change in Working Capital
-â‚ą9.6B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Change in Working Capital
-â‚ą1.1B
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Change in Working Capital
-â‚ą4.6B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Abbott India Ltd
Glance View

Market Cap
605.9B INR
Industry
Pharmaceuticals

Abbott India Ltd., a subsidiary of the global healthcare conglomerate Abbott Laboratories, operates as a key player in India’s pharmaceutical landscape. Nestled in the vibrant, ever-evolving Indian market, Abbott India has carved a niche for itself with a strategic focus on both innovation and localization. Its operations span the development, manufacture, and sale of a wide array of pharmaceutical products. By leveraging Abbott's global expertise and its deep understanding of local market dynamics, the company designs solutions catered to the unique health challenges faced by Indian consumers. Their product portfolio includes a diverse range of proprietary medicines, nutrition products, diagnostics, and branded generics, which address therapeutic areas like cardiology, women's health, gastroenterology, and metabolic disorders. Abbott India’s revenue engine primarily hinges on its extensive distribution networks and its substantial investments in research and development aimed at optimizing treatment paradigms. The company employs a customer-centric approach, working closely with healthcare professionals to ensure the accessibility of its medications across the country. By aligning its operations with the latest trends in healthcare needs and regulatory requirements, Abbott India ensures it remains at the forefront of serving its consumers efficiently. Its commitment to quality and continuous product improvement not only strengthens its market position but also fuels its growth trajectory in the Indian pharmaceutical sector, making it a formidable entity poised for sustained success in a dynamic industry.

ABBOTINDIA Intrinsic Value
16 378.79 INR
Overvaluation 43%
Intrinsic Value
Price
A

See Also

What is Abbott India Ltd's Change in Working Capital?
Change in Working Capital
-2.8B INR

Based on the financial report for Mar 31, 2024, Abbott India Ltd's Change in Working Capital amounts to -2.8B INR.

What is Abbott India Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-18%

Over the last year, the Change in Working Capital growth was 13%. The average annual Change in Working Capital growth rates for Abbott India Ltd have been -7% over the past three years , -18% over the past five years .

Back to Top